XML 34 R18.htm IDEA: XBRL DOCUMENT
v3.20.2

Loss Per Share | 9 Months Ended
--- | ---
Sep. 26, 2020
Earnings Per Share [Abstract] |
Loss Per Share [Text Block] | 11. Loss Per Share Basic and diluted loss per share were calculated as follows (shares in thousands):
|  | Quarter ended |  |  | Three quarters ended |
|  | September 26, 2020 |  |  | September 28, 2019 |  |  | September 26, 2020 |  |  | September 28, 2019 |
Basic Loss Per Share |  |  |  |  |  |  |  |  |  |  |  |
Numerator for basic earnings (loss) per share |  |  |  |  |  |  |  |  |  |  |  |
Earnings (loss) attributable to SunOpta Inc. |  | $89 |  |  | $(11,749) |  |  | $4,457 |  |  | $4,845 |
Less: dividends and accretion on Series A Preferred Stock |  | (2,110) |  |  | (2,009) |  |  | (6,201) |  |  | (6,005) |
Less: dividends and accretion on Series B Preferred Stock |  | (734) |  |  | — |  |  | (1,272) |  |  | — |
Loss attributable to common shareholders |  | $(2,755) |  |  | $(13,758) |  |  | $(3,016) |  |  | $(1,160) |
Denominator for basic earnings (loss) per share |  |  |  |  |  |  |  |  |  |  |  |
Basic weighted-average number of shares outstanding |  | 89,635 |  |  | 87,928 |  |  | 88,962 |  |  | 87,695 |
Basic loss per share |  | $(0.03) |  |  | $(0.16) |  |  | $(0.03) |  |  | $(0.01) |
Diluted Loss Per Share |  |  |  |  |  |  |  |  |  |  |  |
Numerator for diluted earnings (loss) per share |  |  |  |  |  |  |  |  |  |  |  |
Earnings (loss) attributable to SunOpta Inc. | $ | 89 |  | $ | (11,749 | ) | $ | 4,457 |  | $ | 4,845 |
Less: dividends and accretion on Series A Preferred Stock |  | (2,110 | ) |  | (2,009 | ) |  | (6,201 | ) |  | (6,005 | )
Less: dividends and accretion on Series B Preferred Stock |  | (734 | ) |  | — |  |  | (1,272 | ) |  | — |
Loss attributable to common shareholders | $ | (2,755 | ) | $ | (13,758 | ) | $ | (3,016 | ) | $ | (1,160 | )
Denominator for diluted loss per share |  |  |  |  |  |  |  |  |  |  |  |
Basic weighted-average number of shares outstanding |  | 89,635 |  |  | 87,928 |  |  | 88,962 |  |  | 87,695 |
Dilutive effect of the following: |  |  |  |  |  |  |  |  |  |  |  |
Stock options and restricted stock units(1) |  | — |  |  | — |  |  | — |  |  | — |
Series B Preferred Stock(2) |  | — |  |  | — |  |  | — |  |  | — |
Series A Preferred Stock(3) |  | — |  |  | — |  |  | — |  |  | — |
Diluted weighted-average number of shares outstanding |  | 89,635 |  |  | 87,928 |  |  | 88,962 |  |  | 87,695 |
Diluted loss per share | $ | (0.03 | ) | $ | (0.16 | ) | $ | (0.03 | ) | $ | (0.01 | )
(1) For the quarter and three quarters ended September 26, 2020, stock options and restricted stock units to purchase or receive 1,360,975 (September 28, 2019 - 59,981) and 975,742 (September 28, 2019 - 105,486) Common Shares, respectively, were excluded from the calculation of diluted loss per share due to their anti-dilutive effect of reducing the loss per share. In addition, for the quarter and three quarters ended September 26, 2020, stock options to purchase 1,767,856 (September 28, 2019 - 4,248,761) and 3,286,487 (September 28, 2019 - 3,318,583) Common Shares, respectively, were anti-dilutive because the exercise prices of these options were greater than the average market price. (2) For the quarter and three quarters ended September 26, 2020, it was more dilutive to assume the Series B Preferred Stock was not converted into Common Shares and, therefore, the numerator of the diluted earnings per share calculation was not adjusted to add back the dividends and accretion on the Series B Preferred Stock and the denominator was not adjusted to include 12,178,667 Common Shares issuable on an if-converted basis as at September 26, 2020. (3) For the quarters and three quarters ended September 26, 2020 and September 28, 2019, it was more dilutive to assume the Series A Preferred Stock was not converted into Common Shares and, therefore, the numerator of the diluted earnings per share calculation was not adjusted to add back the dividends and accretion on the Series A Preferred Stock and the denominator was not adjusted to include 12,633,429 and 11,333,333 Common Shares issuable on an if-converted basis as at September 26, 2020 and September 28, 2019, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration